Protagonist Therapeutics Inc buy Barclays PLC
Start price
07.11.25
/
50%
€69.00
Target price
07.11.26
€76.27
Performance (%)
18.84%
Price
04.03.26
€82.00
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC currently has a performance of 18.84%. This prediction currently runs until 07.11.26. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | 10.067% | 10.067% |
| iShares Core DAX® | -5,87 % | -2,50 % |
| iShares Nasdaq 100 | 1,66 % | 3,51 % |
| iShares Nikkei 225® | -6,13 % | 2,14 % |
| iShares S&P 500 | 0,50 % | 2,05 % |
Comments by Barclays_PLC for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by analysts at Barclays PLC from $72.00 to $88.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Barclays_PLC for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€77.00
26.02.26
26.02.26
€95.61
26.02.27
26.02.27
6.49%
04.03.26
04.03.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€53.00
17.09.25
17.09.25
€60.73
17.09.26
17.09.26
54.72%
04.03.26
04.03.26